Reactive oxygen species modulator-1 (Romo1) predicts unfavorable prognosis in colorectal cancer patients.
Reactive oxygen species modulator-1 (Romo1) is a novel protein that has been reported to be crucial for cancer cell proliferation and invasion. However, its clinical implications in colorectal cancer patients are not well-known. For the first time, we investigated the association between Romo1 and t...
Main Authors: | Hong Jun Kim, Min Jee Jo, Bo Ram Kim, Jung Lim Kim, Yoon A Jeong, Yoo Jin Na, Seong Hye Park, Suk-Young Lee, Dae-Hee Lee, Hye Seung Lee, Baek-Hui Kim, Sun Il Lee, Byung Wook Min, Young Do Yoo, Sang Cheul Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5417558?pdf=render |
Similar Items
-
Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer
by: Min Jee Jo, et al.
Published: (2020-08-01) -
Overexpression of Romo1 is an unfavorable prognostic biomarker and a predictor of lymphatic metastasis in non-small cell lung cancer patients
by: Kim HJ, et al.
Published: (2018-07-01) -
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
by: Hye-Ra Lee, et al.
Published: (2020-04-01) -
A Novel Peptide Derived from the Transmembrane Domain of Romo1 Is a Promising Candidate for Sepsis Treatment and Multidrug-Resistant Bacteria
by: Deok-Gyun You, et al.
Published: (2021-07-01) -
Loss of YY1 expression predicts unfavorable prognosis in stage III colorectal cancer
by: Hyunsung Kim, et al.
Published: (2021-01-01)